| Literature DB >> 30978662 |
Jan Lukas1, Jola Pospech2, Christina Oppermann3, Christina Hund1, Katharina Iwanov1, Supansa Pantoom1, Janine Petters1, Moritz Frech1, Susanne Seemann1, Franziska-Gisela Thiel4, Jana-Marielle Modenbach4, Robert Bolsmann4, Laura de Freitas Chama4, Franziska Kraatz4, Firas El-Hage2, Manuel Gronbach3, Annelie Klein5, Regina Müller6, Sabine Salloch6, Frank-Ulrich Weiss4, Peter Simon4, Preshit Wagh4, Almuth Klemenz4, Elke Krüger7, Julia Mayerle8, Mihaela Delcea5, Udo Kragl3, Matthias Beller2, Arndt Rolfs1, Markus M Lerch4, Matthias Sendler9.
Abstract
The endoplasmic reticulum (ER) is the site of synthesis and folding of membrane and secretory proteins. The fraction of protein passing through the ER represents a large proportion of the total protein in the cell. Protein folding, glycosylation, sorting and transport are essential tasks of the ER and a compromised ER folding network has been recognized to be a key component in the disease pathogenicity of common neurodegenerative, metabolic and malignant diseases. On the other hand, the ER protein folding machinery also holds significant potential for therapeutic interventions. Many causes can lead to ER stress. A disturbed calcium homeostasis, the generation of reactive oxygen species (ROS) and a persistent overload of misfolded proteins within the ER can drive the course of adisease. In this review the role of ER-stress in diseases of the liver and pancreas will be examined using pancreatitis and Wilson´s disease as examples. Potential therapeutic targets in ER-stress pathways will also be discussed.Entities:
Keywords: ER stress; Endoplasmic reticulum associated protein degradation-ERAD; Pancreatitis; Unfolded protein response; Wilson’s disease
Mesh:
Year: 2019 PMID: 30978662 DOI: 10.1016/j.advms.2019.03.004
Source DB: PubMed Journal: Adv Med Sci ISSN: 1896-1126 Impact factor: 3.287